Agilent Technologies Announces Major NMR/MRI Sale to Adam Mickiewicz University in Poland
June 20, 2011
SANTA CLARA, Calif. - Agilent Technologies Inc. (NYSE: A) today announced a $6 million sale of nuclear magnetic resonance (NMR) spectrometers and magnetic resonance imaging (MRI) systems in collaboration with the Adam Mickiewicz University in Poznan, Poland. The instruments will form the core of the new NanoBioMedical Centre, a multidisciplinary unit supporting master's and doctoral [...]
PerkinElmer Releases 2010 Corporate Social Responsibility Report
June 20, 2011
WALTHAM, Mass. - PerkinElmer, Inc. /quotes/zigman/250499/quotes/nls/pki PKI +1.88% , a global leader focused on improving the health and safety of people and the environment, today announced the publication of its 2010 Corporate Social Responsibility (CSR) Report. The 2010 CSR Report details the Company's progress against its global sustainability goals set in 2009 for environmental health [...]
Neogen Acquires VeroMara from GlycoMar Ltd.
June 20, 2011
LANSING, Mich. - Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the assets of the VeroMara seafood testing laboratory from its parent company, GlycoMar Ltd. Based in Oban, Scotland, VeroMara offers testing services to the shellfish and salmon aquaculture industries. VeroMara's services include testing for shellfish toxins, general foodborne pathogens, including E. coli, [...]
Thermo Fisher Scientific Introduces Expanded Chromatography Portfolio at HPLC 2011
June 20, 2011
BUDAPEST - Thermo Fisher Scientific Inc., the world leader in serving science, today announced it will show its expanded portfolio of market-leading chromatography solutions within the Thermo Scientific and Dionex booths at HPLC 2011, a first since Thermo Fisher acquired Dionex. Among the range of instruments, software and consumables on display will be the newly [...]
IntegenX Proves Rapid Human DNA Identification Utility at DOD Exercise
June 20, 2011
PLEASANTON, CA - IntegenX Inc. (IXI) disclosed today that the company's RapidHIT(TM) 200 Human DNA Identification System repeatedly delivered correct identifications in less than two hours during simulated operational scenarios conducted by the US Department of Defense (DOD). Engineers and technicians from several companies participated in a two-week DOD event featuring tactical scenarios designed to [...]
June 20, 2011
Menlo Park, CA - SwitchGear Genomics, a leading provider of products for studying the regulatory elements in the human genome, today announced the application of its GoClone luciferase reporter products in identifying functional sequence variants that map to expression quantitative trait loci (eQTLs) in a PLoS Genetics article “Identification, Replication, and Functional Fine-Mapping of Expression [...]
June 20, 2011
ETTLINGEN, Germany - Following Bruker's acquisition of Sigma ElectroOptics GmbH in December 2010, Bruker is now launching its expanded product line for the remote infrared detection of gases in industrial, environmental and homeland security applications. The new Bruker Hyperspectral Imaging System HI 90 is an imaging remote chemical sensing system based on the combination of [...]
Phadia First Company to Receive FDA Clearance of Recombinant Allergen Component Tests
June 20, 2011
PORTAGE, Mich. - Phadia, the global leader in allergy and autoimmunity diagnostics, today announced the FDA clearance of recombinant ImmunoCAP® Allergen Components for marketing in the United States. The FDA clearance applies to all of Phadia’s instrument platforms. Phadia was the first diagnostics company to introduce allergen component testing globally and the company will continue [...]
HTG Molecular Diagnostics Appoints Debra Gordon to Vice President, Chief Legal Counsel
June 20, 2011
TUCSON, Ariz. - HTG Molecular Diagnostics, provider of molecular technology solutions, today announced the appointment of Debra Gordon, Ph.D., J.D., to Vice President, Chief Legal Counsel. This announcement comes on the heels of HTG announcing SR One, the corporate venture capital arm of GlaxoSmithKline, joined the company’s investment syndicate. Dr. Gordon will guide the development [...]
Genetic Technologies Launches BREVAGen™ Breast Cancer Risk Test in US
June 20, 2011
VICTORIA, Australia - Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE), through its North American division, Phenogen Sciences Inc., has launched the new BREVAGen™ genetic test for assessing non-familial breast cancer risk. Phenogen Sciences will target its promotion campaign on women's health clinics in over 20 US metro-markets. The company has deployed its sales force to [...]

